Does TRASTUZUMAB-DTTB Cause Ejection fraction decreased? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Ejection fraction decreased have been filed in association with TRASTUZUMAB-DTTB. This represents 3.0% of all adverse event reports for TRASTUZUMAB-DTTB.
15
Reports of Ejection fraction decreased with TRASTUZUMAB-DTTB
3.0%
of all TRASTUZUMAB-DTTB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Ejection fraction decreased From TRASTUZUMAB-DTTB?
Of the 15 reports, 6 (40.0%) required hospitalization.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB-DTTB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB-DTTB Cause?
Diarrhoea (150)
Product use in unapproved indication (89)
Nausea (66)
Pyrexia (65)
Off label use (63)
Anaemia (61)
Vomiting (46)
Hypokalaemia (43)
Chills (40)
Dyspnoea (37)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which TRASTUZUMAB-DTTB Alternatives Have Lower Ejection fraction decreased Risk?
TRASTUZUMAB-DTTB vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB-DTTB vs TRASTUZUMAB-PKRB
TRASTUZUMAB-DTTB vs TRASTUZUMAB-QYYP
TRASTUZUMAB-DTTB vs TRAVOPROST
TRASTUZUMAB-DTTB vs TRAZODONE